Sequential Combination of Low-Intensity Chemotherapy (Mini-hyper-CVD) Plus Inotuzumab Ozogamicin with or without Blinatumomab in Patients with Relapsed/Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (ALL): A Phase 2 Trial
Year: 2018
Type: conference-abstract
Source: Blood
Authors: Koji Sasaki, Hagop M. Kantarjian, Farhad Ravandi, Nicholas J Short, Partow Kebriaei, Xuelin Huang, Michael E. Rytting, Nitin Jain, Marina Y. Konopleva, Guillermo Garcia-Manero, Richard E Champlin, Tapan M. Kadia, Jorge E. Cortes, Zeev E. Estrov, Koichi Takahashi, Morgan Mace, Maria Khouri, Patrice Nasnas, Jovitta Jacob, Rebecca E. Garris, Elias J. Jabbour
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2911262754